Circulating endothelial cells

AD Blann, A Woywodt, F Bertolini… - Thrombosis and …, 2005 - thieme-connect.com
Recent research has recognised new populations of non-hematopoïetic cells in the blood.
One of these, circulating endothelial cells (CECs), often defined by the expression of …

Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody‐associated congenital heart block: retrospective review of the research …

S Saleeb, J Copel, D Friedman… - Arthritis & Rheumatism …, 1999 - Wiley Online Library
Objective To compare intervention with fluorinated glucocorticoids to the natural history of
untreated congenital heart block (CHB) with respect to conduction abnormalities, associated …

The clinical spectrum of autoimmune congenital heart block

P Brito-Zerón, PM Izmirly, M Ramos-Casals… - Nature Reviews …, 2015 - nature.com
Autoimmune congenital heart block (CHB) is an immune-mediated acquired disease that is
associated with the placental transference of maternal antibodies specific for Ro and La …

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

M Petri, AM Orbai, GS Alarcón, C Gordon… - Arthritis & …, 2012 - Wiley Online Library
Abstract Objective The Systemic Lupus International Collaborating Clinics (SLICC) group
revised and validated the American College of Rheumatology (ACR) systemic lupus …

[HTML][HTML] Combined oral contraceptives in women with systemic lupus erythematosus

M Petri, MY Kim, KC Kalunian… - … England Journal of …, 2005 - Mass Medical Soc
Background Oral contraceptives are rarely prescribed for women with systemic lupus
erythematosus, because of concern about potential negative side effects. In this double …

[HTML][HTML] Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

EM Ginzler, MA Dooley, C Aranow… - … England Journal of …, 2005 - Mass Medical Soc
Background Since anecdotal series and small, prospective, controlled trials suggest that
mycophenolate mofetil may be effective for treating lupus nephritis, larger trials are …

Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry

JP Buyon, R Hiebert, J Copel, J Craft… - Journal of the American …, 1998 - jacc.org
Objectives. The present study describes the demographics, mortality, morbidity and
recurrence rates of autoimmune-associated congenital heart block (CHB) using information …

The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial

JP Buyon, MA Petri, MY Kim, KC Kalunian… - Annals of internal …, 2005 - acpjournals.org
Background: There is concern that exogenous female hormones may worsen disease
activity in women with systemic lupus erythematosus (SLE). Objective: To evaluate the effect …

The immune cell landscape in kidneys of patients with lupus nephritis

A Arazi, DA Rao, CC Berthier, A Davidson, Y Liu… - Nature …, 2019 - nature.com
Lupus nephritis is a potentially fatal autoimmune disease for which the current treatment is
ineffective and often toxic. To develop mechanistic hypotheses of disease, we analyzed …

The role of nitric oxide in the pathogenesis of preeclampsia

SP Seligman, JP Buyon, RM Clancy, BK Young… - American journal of …, 1994 - Elsevier
Objective: Nitric oxide, a potent vasodilator released by endothelial cells, inhibits platelet
aggregation and adhesion to vascular endothelial surfaces. Because endothelial cell …